2019 Annual CCO Hepatitis Symposium

Register now for this complimentary event in San Francisco!

The annual CCO symposium returns in 2019 with an efficient half-day format, enabling you to learn about all the important clinical advances without taking days away from your workplace.

The meeting will focus on the latest updates in viral hepatitis management, incorporating all of the latest data from the EASL meeting, through a highly interactive combination of didactic presentations, case-based learning, and expert panel discussions.

 

Agenda

8:15 AM Program Overview
Chair: Ira M. Jacobson, MD

8:30 AM Interactive Plenary: Simplifying HCV Assessment and Treatment
Faculty:
Jordan J. Feld, MD, MPH

9:00 AM Interactive Roundtable: Treating to Eliminate HCV: Case Discussion
Moderator: Nancy Reau, MD, FAASLD, AGAF

10:00 AM Question and Answer Session

10:30 AM Interactive Plenary: Treating Hepatitis B Now and in the Future
Faculty: Paul Y. Kwo, MD

11:00 AM Interactive Roundtable: Current Controversies and Challenging Cases in HBV Management
Moderator:
Marion G. Peters, MD, FRACP 

12:00 PM Question and Answer Session

12:30 PM Adjournment

Events

Date / Time
Event Details

Faculty

Program Chair
Ira M. Jacobson, MD

Director of Hepatology
Department of Medicine
NYU School of Medicine
New York, New York

Faculty
Jordan J. Feld, MD, MPH

Associate Professor of Medicine
University of Toronto
Hepatologist
Toronto Centre for Liver Disease
Sandra Rotman Centre for Global Health
Toronto, Canada

Faculty
Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Faculty
Marion G. Peters, MD, FRACP

Chief of Hepatology Research
Professor of Medicine, Gastroenterology
University of California, San Francisco
San Francisco, California

Faculty
Nancy Reau, MD

Professor of Medicine
Chief,
Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Program Overview
The primary purpose of this program is to arm clinicians with tools to address the most important and most current challenges in viral hepatitis management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic. The program will consist of 2 live half-day highly interactive workshops dedicated to viral hepatitis. 

Goal Statement
The goal of this activity is to improve participants’ competence in addressing the most important and most current challenges in HIV and viral hepatitis management by providing a tightly focused update on recent advances and key clinical issues encountered in the clinic.

Target Audience 
This program is intended for HIV specialists, infectious diseases clinicians, hepatologists, gastroenterologists, registered nurses, pharmacists, and other healthcare professionals involved in the care of patients with HIV infection and/or viral hepatitis.

Learning Objectives

  • Integrate the results of clinical studies of approved viral hepatitis treatments into optimized patient management strategies
  • Apply key guidelines and study data to ensure appropriate, individualized management for diverse patient populations with viral hepatitis infection, based on individual patient factors
  • Implement practical strategies to optimize outcomes in individuals with viral hepatitis

Accreditation

Physician Continuing Medical Education

Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
4.2 contact hours may be earned for successful completion of this activity.

California Board of Registered Nursing 
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 4.2 contact hours.

Pharmacist Continuing Education

Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
This program has been assigned ACPE Universal Activity #0797-9999-19-037-L01-P. This program is designated for up to 4.25 contact hours (0.425 CEUs) of continuing pharmacy education credit.

Type of Activity: Application

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Disclosure of Conflicts of Interest 
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.